Bayesian Capital Management, LP Tandem Diabetes Care Inc Transaction History
Bayesian Capital Management, LP
- $600 Million
- Q2 2025
A detailed history of Bayesian Capital Management, LP transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Bayesian Capital Management, LP holds 28,400 shares of TNDM stock, worth $441,336. This represents 0.09% of its overall portfolio holdings.
Number of Shares
28,400Holding current value
$441,336% of portfolio
0.09%Shares
11 transactions
Others Institutions Holding TNDM
# of Institutions
301Shares Held
81.6MCall Options Held
2.87MPut Options Held
134K-
Black Rock Inc. New York, NY11.1MShares$173 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.37MShares$115 Million0.0% of portfolio
-
Sessa Capital Im, L.P. New York, NY5MShares$77.7 Million2.82% of portfolio
-
Gw&K Investment Management, LLC Boston, MA2.89MShares$44.9 Million0.48% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO2.7MShares$42 Million1.02% of portfolio
About TANDEM DIABETES CARE INC
- Ticker TNDM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 64,221,200
- Market Cap $998M
- Description
- Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...